Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 20Terminated 4Recruiting 4Active not recruiting 4Unknown 3Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 50Carcinoma, Non-Small-Cell Lung 36Ovarian Neoplasms 35Stomach Neoplasms 32Esophageal Neoplasms 29Uterine Cervical Neoplasms 21Esophageal Squamous Cell Carcinoma 19Fallopian Tube Neoplasms 16Lung Neoplasms 13Carcinoma, Ovarian Epithelial 13Neoplasms 9Head and Neck Neoplasms 9Carcinoma, Squamous Cell 9Triple Negative Breast Neoplasms 8Recurrence 8Neoplasm Metastasis 6Endometrial Neoplasms 6Advanced Gastric Cancer 6Squamous Cell Carcinoma of Head and Neck 5Pancreatic Neoplasms 5Nasopharyngeal Neoplasms 5Hypopharyngeal Neoplasms 4Oropharyngeal Neoplasms 3Nasopharyngeal Carcinoma 3Mouth Neoplasms 3Melanoma 3Laryngeal Neoplasms 3Carcinoma 3Anus Neoplasms 3Adenocarcinoma Of Esophagus 3

Interventions

Fluorouracil 5Radiotherapy 3Paclitaxel 3Leucovorin 3Endoscopy 3Cisplatin 3Oxaliplatin 2Neoadjuvant Therapy 2Endoscopy, Digestive System 2Endoscopic Mucosal Resection 2Carboplatin 2tremelimumab 1rucaparib 1rubitecan 1durvalumab 1Taxes 1Surveys and Questionnaires 1Ramucirumab 1Radiation 1Positron Emission Tomography Computed Tomography 1Nivolumab 1Microarray Analysis 1Magnetic Resonance Imaging 1Irinotecan 1High-Throughput Screening Assays 1Genetic Linkage 1Epirubicin 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Drug Therapy 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Adenocarcinoma Of Esophagus × Paclitaxel × Clear all
NCT02509286 2024-05-08

ESOPEC

University Hospital Schleswig-Holstein

Phase 3 Unknown
438 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT02037048 2024-01-08

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

Case Comprehensive Cancer Center

Phase 2 Unknown
63 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00003326 2008-07-24

Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus

National Cancer Institute (NCI)

Phase 2 Unknown
100 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡